0001752724-20-194168.txt : 20200925 0001752724-20-194168.hdr.sgml : 20200925 20200925132916 ACCESSION NUMBER: 0001752724-20-194168 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20200731 FILED AS OF DATE: 20200925 PERIOD START: 20201031 FILER: COMPANY DATA: COMPANY CONFORMED NAME: T. Rowe Price Global Funds, Inc. CENTRAL INDEX KEY: 0000852254 IRS NUMBER: 000000000 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-05833 FILM NUMBER: 201198636 BUSINESS ADDRESS: STREET 1: 100 EAST PRATT STREET CITY: BALTIMORE STATE: MD ZIP: 21202 BUSINESS PHONE: 410-345-2000 MAIL ADDRESS: STREET 1: 100 EAST PRATT STREET CITY: BALTIMORE STATE: MD ZIP: 21202 FORMER COMPANY: FORMER CONFORMED NAME: T. Rowe Price Institutional International Funds, Inc. DATE OF NAME CHANGE: 20051028 FORMER COMPANY: FORMER CONFORMED NAME: T ROWE PRICE INSTITUTIONAL INTERNATIONAL FUNDS INC DATE OF NAME CHANGE: 20011217 FORMER COMPANY: FORMER CONFORMED NAME: INSTITUTIONAL INTERNATIONAL FUNDS INC DATE OF NAME CHANGE: 19920703 0000852254 S000029530 T. Rowe Price Institutional International Disciplined Equity Fund C000090615 T. Rowe Price Institutional International Disciplined Equity Fund RPICX NPORT-P 1 primary_doc.xml NPORT-P false 0000852254 XXXXXXXX S000029530 C000090615 T. ROWE PRICE GLOBAL FUNDS, INC. 811-05833 0000852254 5493007HG7742XS78J80 100 East Pratt Street Baltimore 21202 410-345-2000 T. Rowe Price Institutional International Disciplined Equity Fund S000029530 7D4X82TRE4PUE27U6W16 2020-10-31 2020-07-31 N 286057861.69 1231749.87 284826111.82 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 303240.50000000 N Barry Callebaut AG 213800Y5RWKLDPUTT265 Barry Callebaut AG 000000000 2445.00000000 NS 5091271.38000000 1.787501625980 Long EC CORP CH N 2 N N N Thales SA 529900FNDVTQJOVVPZ19 Thales SA 000000000 65189.00000000 NS 4712617.81000000 1.654559611788 Long EC CORP FR N 2 N N N Tricon Residential Inc N/A Tricon Residential Inc 89612W102 511017.00000000 NS 3662520.59000000 1.285879502618 Long EC CORP CA N 2 N N N Nestle SA KY37LUS27QQX7BB93L28 Nestle SA 000000000 49063.00000000 NS 5834658.36000000 2.048498405822 Long EC CORP CH N 2 N N N Wendel SE 969500M98ZMIZYJD5O34 Wendel SE 000000000 44870.00000000 NS 4211326.64000000 1.478560590210 Long EC CORP FR N 2 N N N Eni SpA BUCRF72VH5RBN7X3VL35 Eni SpA 000000000 401826.00000000 NS 3579400.07000000 1.256696602403 Long EC CORP IT N 2 N N N GlaxoSmithKline PLC 5493000HZTVUYLO1D793 GlaxoSmithKline PLC 000000000 181394.00000000 NS 3613434.76000000 1.268645889560 Long EC CORP GB N 2 N N N Smith & Nephew PLC 213800ZTMDN8S67S1H61 Smith & Nephew PLC 000000000 194785.00000000 NS 3844574.28000000 1.349796988567 Long EC CORP GB N 2 N N N Ontex Group NV 549300AQESC6JJOPW253 Ontex Group NV 000000000 267042.00000000 NS 3818838.27000000 1.340761296637 Long EC CORP BE N 2 N N N Schneider Electric SE 969500A1YF1XUYYXS284 Schneider Electric SE 000000000 18847.00000000 NS 2161069.65000000 0.758732981393 Long EC CORP FR N 2 N N N Heineken NV 724500K5PTPSST86UQ23 Heineken NV 000000000 49308.00000000 NS 4775794.70000000 1.676740474910 Long EC CORP NL N 2 N N N Kirin Holdings Co Ltd 353800GBVL72LLMTYM96 Kirin Holdings Co Ltd 497350108 213400.00000000 NS 4111936.57000000 1.443665590814 Long EC CORP JP N 2 N N N Prosus NV 635400Z5LQ5F9OLVT688 Prosus NV 000000000 37284.00000000 NS 3628747.27000000 1.274021980222 Long EC CORP NL N 2 N N N Daimler AG 529900R27DL06UVNT076 Daimler AG 000000000 47568.00000000 NS 2079870.47000000 0.730224647139 Long EC CORP DE N 2 N N N Sampo Oyj 743700UF3RL386WIDA22 Sampo Oyj 000000000 104129.00000000 NS 3763676.44000000 1.321394452197 Long EC CORP FI N 2 N N N Ipsen SA 549300M6SGDPB4Z94P11 Ipsen SA 000000000 27553.00000000 NS 2642405.24000000 0.927725770335 Long EC CORP FR N 2 N N N HAL Trust 5493000O3IE3DNOY3R07 HAL Trust 000000000 30262.00000000 NS 4000236.40000000 1.404448621103 Long EC CORP CW N 2 N N N Hoya Corp 353800X4VR3BHEUCJB42 Hoya Corp 000000000 26300.00000000 NS 2593692.97000000 0.910623310983 Long EC CORP JP N 2 N N N Roche Holding AG 549300U41AUUVOAAOB37 Roche Holding AG 000000000 15843.00000000 NS 5487327.05000000 1.926553367925 Long EC CORP CH N 2 N N N BHP Group PLC 549300C116EOWV835768 BHP Group PLC 000000000 233103.00000000 NS 5040498.64000000 1.769675753319 Long EC CORP AU N 2 N N N Mitsubishi Electric Corp 549300TRXM9Y6561AX39 Mitsubishi Electric Corp 000000000 340300.00000000 NS 4442301.27000000 1.559653797755 Long EC CORP JP N 2 N N N Shimano Inc 529900L32YT3P9DECR10 Shimano Inc 000000000 11800.00000000 NS 2562226.49000000 0.899575700285 Long EC CORP JP N 2 N N N Industrivarden AB 549300TM1DLIQI3B3T37 Industrivarden AB 000000000 147548.00000000 NS 3639637.22000000 1.277845348076 Long EC CORP SE N 2 N N N Suntory Beverage & Food Ltd 549300FONLMVK7YYYH41 Suntory Beverage & Food Ltd 000000000 124300.00000000 NS 4691857.20000000 1.647270740038 Long EC CORP JP N 2 N N N ASML Holding NV 724500Y6DUVHQD6OXN27 ASML Holding NV 000000000 8789.00000000 NS 3124829.45000000 1.097100764404 Long EC CORP NL N 2 N N N Astellas Pharma Inc 529900IB708DY2HBBB35 Astellas Pharma Inc 000000000 181300.00000000 NS 2827911.18000000 0.992855311589 Long EC CORP JP N 2 N N N TOTAL SE 529900S21EQ1BO4ESM68 TOTAL SE 000000000 133807.00000000 NS 5063765.21000000 1.777844446087 Long EC CORP FR N 2 N N N Sanofi 549300E9PC51EN656011 Sanofi 000000000 45365.00000000 NS 4763204.98000000 1.672320332417 Long EC CORP FR N 2 N N N Sprott Physical Gold and Silver Trust N/A Sprott Physical Gold and Silver Trust 85208R101 166260.00000000 NS USD 3270334.20000000 1.148186231628 Long EC RF CA N 1 N N N Red Electrica Corp SA 5493009HMD0C90GUV498 Red Electrica Corp SA 000000000 243311.00000000 NS 4743312.70000000 1.665336323868 Long EC CORP ES N 2 N N N UBS Group AG 549300SZJ9VS8SGXAN81 UBS Group AG 000000000 279338.00000000 NS 3290820.07000000 1.155378644525 Long EC CORP CH N 2 N N N Vodafone Group PLC 213800TB53ELEUKM7Q61 Vodafone Group PLC 000000000 2602341.00000000 NS 3910937.96000000 1.373096706270 Long EC CORP GB N 2 N N N CK Hutchison Holdings Ltd 254900Z8HM1VEPOQ2G79 CK Hutchison Holdings Ltd 000000000 724692.00000000 NS 4732094.40000000 1.661397675150 Long EC CORP HK N 2 N N N Metso Outotec Oyj 549300R0VN9C371W0E07 Metso Outotec Oyj 000000000 451830.00000000 NS 2916068.18000000 1.023806476648 Long EC CORP FI N 2 N N N Koninklijke Philips NV H1FJE8H61JGM1JSGM897 Koninklijke Philips NV 000000000 72246.00000000 NS 3733024.91000000 1.310632963440 Long EC CORP NL N 2 N N N Otsuka Holdings Co Ltd N/A Otsuka Holdings Co Ltd 000000000 117700.00000000 NS 4881435.61000000 1.713830090509 Long EC CORP JP N 2 N N N Siemens AG W38RGI023J3WT1HWRP32 Siemens AG 000000000 22459.00000000 NS 2862094.27000000 1.004856700711 Long EC CORP DE N 2 N N N Informa PLC 5493006VM2LKUPSEDU20 Informa PLC 000000000 498603.00000000 NS 2364176.71000000 0.830042124611 Long EC CORP GB N 2 N N N Deutsche Telekom AG 549300V9QSIG4WX4GJ96 Deutsche Telekom AG 000000000 161347.00000000 NS 2693655.46000000 0.945719282121 Long EC CORP DE N 2 N N N Novartis AG 5493007HIVTX6SY6XD66 Novartis AG 000000000 68982.00000000 NS 5681859.97000000 1.994852204277 Long EC CORP CH N 2 N N N Great Portland Estates PLC 213800JMEDD2Q4N1MC42 Great Portland Estates PLC 000000000 462726.00000000 NS 3568205.91000000 1.252766429032 Long EC CORP GB N 2 N N N Unilever NV 549300TK7G7NZTVM1Z30 Unilever NV 000000000 68274.00000000 NS 4034342.02000000 1.416422811174 Long EC CORP GB N 2 N N N Continental AG 529900A7YD9C0LLXM621 Continental AG 000000000 29193.00000000 NS 2820016.67000000 0.990083616976 Long EC CORP DE N 2 N N N National Grid PLC 8R95QZMKZLJX5Q2XR704 National Grid PLC 000000000 267035.00000000 NS 3132832.17000000 1.099910450619 Long EC CORP GB N 2 N N N Wartsila OYJ Abp 743700G7A9J1PHM3X223 Wartsila OYJ Abp 000000000 176067.00000000 NS 1472605.61000000 0.517019173765 Long EC CORP FI N 2 N N N Henkel AG & Co KGaA 549300VZCL1HTH4O4Y49 Henkel AG & Co KGaA 000000000 44757.00000000 NS 4400737.63000000 1.545061160958 Long EP CORP DE N 2 N N N Bayer AG 549300J4U55H3WP1XT59 Bayer AG 000000000 57880.00000000 NS 3845180.33000000 1.350009767513 Long EC CORP DE N 2 N N N Smiths Group PLC 213800MJL6IPZS3ASA11 Smiths Group PLC 000000000 136918.00000000 NS 2412017.24000000 0.846838523542 Long EC CORP GB N 2 N N N Munich Re 529900MUF4C20K50JS49 Muenchener Rueckversicherungs-Gesellschaft AG in Muenchen 000000000 13055.00000000 NS 3460542.49000000 1.214966727554 Long EC CORP DE N 2 N N N Samsonite International SA 549300UULS5HYFJSEL12 Samsonite International SA 000000000 2581200.00000000 NS 2419315.63000000 0.849400925547 Long EC CORP US N 2 N N N Millicom International Cellula 549300CTHC1CP86P2G96 Millicom International Cellular SA 000000000 106322.00000000 NS 3200236.94000000 1.123575686074 Long EC CORP LU N 2 N N N Hoshizaki Corp 5299001QAMLGU3SRBG20 Hoshizaki Corp 000000000 53100.00000000 NS 4047835.61000000 1.421160294656 Long EC CORP JP N 2 N N N EssilorLuxottica SA 549300M3VH1A3ER1TB49 EssilorLuxottica SA 000000000 30665.00000000 NS 4084435.98000000 1.434010370011 Long EC CORP FR N 2 N N N Investor AB 549300VEBQPHRZBKUX38 Investor AB 000000000 62768.00000000 NS 3724316.49000000 1.307575512021 Long EC CORP SE N 2 N N N Amcor PLC 549300GSODGFCDQ3DI89 Amcor PLC 000000000 290806.00000000 NS 2986802.89000000 1.048640825419 Long EC CORP GB N 2 N N N PRADA SpA 8156000FE0A2DC5B7852 PRADA SpA 000000000 942900.00000000 NS 3639862.09000000 1.277924298001 Long EC CORP IT N 2 N N N Power Corp of Canada 549300BE2CB8T87IJV50 Power Corp of Canada 739239101 223100.00000000 NS 3959152.64000000 1.390024466051 Long EC CORP CA N 2 N N N Brookfield Asset Management In C6J3FGIWG6MBDGTE8F80 Brookfield Asset Management Inc 112585104 112500.00000000 NS 3633394.30000000 1.275653512517 Long EC CORP CA N 2 N N N Groupe Bruxelles Lambert SA 549300KV0ZEHT2KVU152 Groupe Bruxelles Lambert SA 000000000 95117.00000000 NS 8250527.00000000 2.896689122805 Long EC CORP BE N 2 N N N JCDecaux SA 9695009KV7AFPDEI5S30 JCDecaux SA 000000000 172778.00000000 NS 2922593.96000000 1.026097621922 Long EC CORP FR N 2 N N N Amadeus IT Group SA 9598004A3FTY3TEHHN09 Amadeus IT Group SA 000000000 67929.00000000 NS 3392062.52000000 1.190923998619 Long EC CORP ES N 2 N N N Asics Corp 3538002LJMRZ83SU0B85 Asics Corp 000000000 324000.00000000 NS 3614639.44000000 1.269068842355 Long EC CORP JP N 2 N N N Beiersdorf AG L47NHHI0Z9X22DV46U41 Beiersdorf AG 000000000 29910.00000000 NS 3571429.02000000 1.253898035253 Long EC CORP DE N 2 N N N H Lundbeck A/S 5493006R4KC2OI5D3470 H Lundbeck A/S 000000000 70606.00000000 NS 2574301.50000000 0.903815132520 Long EC CORP DK N 2 N N N T. ROWE PRICE GOVERNMENT RESERVE FUND 5493002Y0IYARJVQ5N24 T. ROWE PRICE GOVERNMENT RESERVE FUND 76105Y109 23530500.06000000 NS USD 23530500.06000000 8.261356344628 Long STIV RF US N 1 N N N Japan Tobacco Inc 353800Z0ENYBQO0XRJ31 Japan Tobacco Inc 000000000 228100.00000000 NS 3898789.46000000 1.368831472327 Long EC CORP JP N 2 N N N Mitsubishi Corp KVIPTY4PULAPGC1VVD26 Mitsubishi Corp 000000000 221100.00000000 NS 4455119.56000000 1.564154189211 Long EC CORP JP N 2 N N N BASF SE 529900PM64WH8AF1E917 BASF SE 000000000 58709.00000000 NS 3238754.19000000 1.137098761523 Long EC CORP DE N 2 N N N BAE Systems PLC 8SVCSVKSGDWMW2QHOH83 BAE Systems PLC 000000000 676303.00000000 NS 4334373.99000000 1.521761457298 Long EC CORP GB N 2 N N N NTT 353800VHQU5VIXVUA841 Nippon Telegraph & Telephone Corp 000000000 147100.00000000 NS 3414405.92000000 1.198768574335 Long EC CORP JP N 2 N N N 2020-09-24 T. ROWE PRICE INSTITUTIONAL INTERNATIONAL FUNDS, INC. Alan S. Dupski Alan S. Dupski Treasurer & Vice President XXXX NPORT-EX 2 70AQTRPInstitIntlDiscEqFd.htm aqtroweinstitutionalinternat.htm - Generated by SEC Publisher for SEC Filing

T. ROWE PRICE INSTITUTIONAL INTERNATIONAL DISCIPLINED EQUITY FUND
July 31, 2020 (Unaudited)

Portfolio of Investments  Shares  $ Value    Shares  $ Value 
(Cost and value in $000s)      (Cost and value in $000s)     
BELGIUM 4.2%      Thales  65,949  4,768 
      TOTAL  134,568  5,093 
Common Stocks 4.2%      Wendel  44,870  4,211 
Groupe Bruxelles Lambert  95,117  8,250  Total France     
Ontex Group (1)  267,042  3,819  (Cost $31,218)    30,732 
Total Belgium           
(Cost $11,827)    12,069  GERMANY 10.2%     
 
CANADA 5.1%      Common Stocks 8.7%     
      BASF  59,215  3,267 
Common Stocks 5.1%      Bayer  58,306  3,873 
Brookfield Asset Management,      Beiersdorf  29,910  3,571 
   Class A  114,300  3,692  Continental  29,193  2,820 
Power Corp of Canada  223,100  3,959  Daimler  51,329  2,244 
Sprott Physical Gold & Silver      Deutsche Telekom  161,347  2,694 
  Trust (USD) (1)(2)  166,260  3,270  Munich Re  13,055  3,461 
Tricon Residential  511,017  3,663  Siemens  22,459  2,862 
 
Total Canada          24,792 
(Cost $13,181)    14,584       
      Preferred Stocks 1.5%     
DENMARK 0.9%      Henkel (3)  44,757  4,401 
          4,401 
Common Stocks 0.9%      Total Germany     
H Lundbeck  70,606  2,574  (Cost $28,072)    29,193 
Total Denmark           
(Cost $2,568)    2,574  HONG KONG 2.5%     
 
FINLAND 2.9%      Common Stocks 2.5%     
      CK Hutchison Holdings  724,692  4,732 
Common Stocks 2.9%      Samsonite International (1)  2,581,200  2,420 
Metso Outotec  451,830  2,916  Total Hong Kong     
Sampo, A Shares  104,129  3,764  (Cost $10,611)    7,152 
Wartsila  176,067  1,472       
Total Finland      ITALY 2.6%     
(Cost $7,541)    8,152       
      Common Stocks 2.6%     
FRANCE 10.8%      Eni  414,254  3,690 
      PRADA (HKD) (1)  942,900  3,640 
Common Stocks 10.8%      Total Italy     
EssilorLuxottica (1)  30,876  4,113  (Cost $8,017)    7,330 
Ipsen  27,553  2,642       
JCDecaux (1)  176,242  2,981       
Sanofi  45,365  4,763       
Schneider Electric  18,847  2,161       

 

The accompanying notes are an integral part of this Portfolio of Investments.


 

T. ROWE PRICE INSTITUTIONAL INTERNATIONAL DISCIPLINED EQUITY FUND

  Shares  $ Value    Shares  $ Value 
(Cost and value in $000s)      (Cost and value in $000s)     
 
JAPAN 16.0%      Millicom International Cellular,     
          SDR  101,463  3,054 
Common Stocks 16.0%      Total Sweden     
Asics  324,000  3,615  (Cost $8,031)    10,418 
Astellas Pharma  181,300  2,828       
Hoshizaki  53,100  4,048  SWITZERLAND 8.9%     
Hoya  26,300  2,594       
Japan Tobacco  228,100  3,899  Common Stocks 8.9%     
Kirin Holdings  213,400  4,112  Barry Callebaut  2,445  5,091 
Mitsubishi  222,500  4,483  Nestle  49,063  5,835 
Mitsubishi Electric  340,300  4,442  Novartis  68,982  5,682 
Nippon Telegraph & Telephone  147,100  3,414  Roche Holding  15,843  5,487 
Otsuka Holdings  117,700  4,881  UBS Group  279,338  3,291 
Shimano  11,800  2,562       
Suntory Beverage & Food  124,300  4,692  Total Switzerland     
      (Cost $19,830)    25,386 
Total Japan           
(Cost $43,523)    45,570  UNITED KINGDOM 12.4%     
NETHERLANDS 8.2%      Common Stocks 12.4%     
      Amcor, CDI (AUD)  290,806  2,987 
Common Stocks 8.2%      BAE Systems  676,303  4,334 
ASML Holding  8,789  3,125  BHP Group  233,103  5,041 
HAL Trust  30,262  4,000  GlaxoSmithKline  181,394  3,613 
Heineken  49,308  4,776  Great Portland Estates  462,726  3,568 
Koninklijke Philips (1)  72,246  3,733  Informa  498,603  2,364 
Prosus (1)  37,284  3,629  National Grid  267,035  3,133 
Unilever  68,274  4,034  Smith & Nephew  194,785  3,845 
Total Netherlands      Smiths Group  136,918  2,412 
(Cost $18,295)    23,297  Vodafone Group  2,620,806  3,939 
      Total United Kingdom     
SPAIN 2.8%      (Cost $33,870)    35,236 
 
Common Stocks 2.8%      SHORT-TERM INVESTMENTS 8.3%   
Amadeus IT Group, A Shares  67,929  3,392       
Red Electrica  243,311  4,743  MONEY MARKET FUNDS 8.3%     
Total Spain      T. Rowe Price Government Reserve     
(Cost $7,506)    8,135     Fund, 0.13% (4)(5)  23,533,146  23,533 
      Total Short-Term Investments     
SWEDEN 3.7%      (Cost $23,533)    23,533 
 
Common Stocks 3.7%      Total Investments in Securities 99.5%     
Industrivarden, C Shares (1)  147,548  3,640       
Investor, B Shares  62,768  3,724  (Cost $267,623)  $  283,361 
      Other Assets Less Liabilities 0.5%    1,468 
      Net Assets 100%  $  284,829 

 

The accompanying notes are an integral part of this Portfolio of Investments.


 

T. ROWE PRICE INSTITUTIONAL INTERNATIONAL DISCIPLINED EQUITY FUND

  Country classifications are generally based on MSCI categories or another unaffiliated third party data provider; Shares are 
    denominated in the currency of the country presented unless otherwise noted. 
(1 )  Non-income producing 
(2 )  Organized as a closed-end management investment company. 
(3 )  Preferred stocks are shares that carry certain preferential rights. The dividend rate may not be consistent each pay period 
    and could be zero for a particular year. 
(4 )  Seven-day yield 
(5 )  Affiliated Companies 
AUD   Australian Dollar 
CDI   CHESS or CREST Depositary Interest 
HKD   Hong Kong Dollar 
SDR   Swedish Depositary Receipts 
USD   U. S. Dollar 

 

The accompanying notes are an integral part of this Portfolio of Investments.


 

T. ROWE PRICE INSTITUTIONAL INTERNATIONAL DISCIPLINED EQUITY FUND

Affiliated Companies
($000s)

The fund may invest in certain securities that are considered affiliated companies. As defined by the 1940 Act, an affiliated company is one in
which the fund owns 5% or more of the outstanding voting securities, or a company that is under common ownership or control. The following
securities were considered affiliated companies for all or some portion of the nine months ended July 31, 2020. Net realized gain (loss),
investment income, change in net unrealized gain/loss, and purchase and sales cost reflect all activity for the period then ended.

        Change in Net     
    Net Realized Gain    Unrealized    Investment 
Affiliate      (Loss)    Gain/Loss    Income 
T. Rowe Price Government Reserve Fund    $    $    $ 186 
T. Rowe Price Short-Term Fund              —++ 
Totals    $  —#  $    $ 186+ 
 
 
Supplementary Investment Schedule               
    Value  Purchase  Sales    Value 
Affiliate    10/31/19  Cost  Cost    7/31/20 
T. Rowe Price Government Reserve Fund  $ 29,610    ¤  ¤ $    23,533 
T. Rowe Price Short-Term Fund        ¤  ¤     
Total          $    23,533^ 

 

# Capital gain distributions from mutual funds represented $0 of the net realized gain (loss).
++ Excludes earnings on securities lending collateral, which are subject to rebates and fees.
+ Investment income comprised $186 of dividend income and $0 of interest income.
¤ Purchase and sale information not shown for cash management funds.
^ The cost basis of investments in affiliated companies was $23,533.

The accompanying notes are an integral part of this Portfolio of Investments.


 

T. ROWE PRICE INSTITUTIONAL INTERNATIONAL DISCIPLINED EQUITY FUND
Unaudited
NOTES TO PORTFOLIO OF
INVESTMENTS

T. Rowe Price Institutional International Disciplined Equity Fund (the fund) is registered under the Investment
Company Act of 1940 (the 1940 Act) as an open-end management investment company and follows accounting and
reporting guidance of the Financial Accounting Standards Board Accounting Standards Codification Topic 946. The
accompanying Portfolio of Investments was prepared in accordance with accounting principles generally accepted in the
United States of America (GAAP). For additional information on the fund’s significant accounting policies and investment
related disclosures, please refer to the fund’s most recent semiannual or annual shareholder report and its prospectus.

VALUATION

The fund’s financial instruments are valued at the close of the New York Stock Exchange (NYSE), normally 4 p.m. ET,
each day the NYSE is open for business.

Fair Value
The fund’s financial instruments are reported at fair value, which GAAP defines as the price that would be received to
sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement
date. The T. Rowe Price Valuation Committee (the Valuation Committee) is an internal committee that has been
delegated certain responsibilities by the fund’s Board of Directors (the Board) to ensure that financial instruments are
appropriately priced at fair value in accordance with GAAP and the 1940 Act. Subject to oversight by the Board, the
Valuation Committee develops and oversees pricing-related policies and procedures and approves all fair value
determinations. Specifically, the Valuation Committee establishes procedures to value securities; determines pricing
techniques, sources, and persons eligible to effect fair value pricing actions; oversees the selection, services, and
performance of pricing vendors; oversees valuation-related business continuity practices; and provides guidance on
internal controls and valuation-related matters. The Valuation Committee reports to the Board and has representation
from legal, portfolio management and trading, operations, risk management, and the fund’s treasurer.

Various valuation techniques and inputs are used to determine the fair value of financial instruments. GAAP
establishes the following fair value hierarchy that categorizes the inputs used to measure fair value:

Level 1 - quoted prices (unadjusted) in active markets for identical financial instruments that the fund can access at
the reporting date

Level 2 - inputs other than Level 1 quoted prices that are observable, either directly or indirectly (including, but not
limited to, quoted prices for similar financial instruments in active markets, quoted prices for identical or
similar financial instruments in inactive markets, interest rates and yield curves, implied volatilities, and
credit spreads)

Level 3 - unobservable inputs

Observable inputs are developed using market data, such as publicly available information about actual events or
transactions, and reflect the assumptions that market participants would use to price the financial instrument.
Unobservable inputs are those for which market data are not available and are developed using the best information
available about the assumptions that market participants would use to price the financial instrument. GAAP requires
valuation techniques to maximize the use of relevant observable inputs and minimize the use of unobservable inputs.
When multiple inputs are used to derive fair value, the financial instrument is assigned to the level within the fair value
hierarchy based on the lowest-level input that is significant to the fair value of the financial instrument. Input levels are
not necessarily an indication of the risk or liquidity associated with financial instruments at that level but rather the
degree of judgment used in determining those values.

Valuation Techniques
Equity securities listed or regularly traded on a securities exchange or in the over-the-counter (OTC) market are valued
at the last quoted sale price or, for certain markets, the official closing price at the time the valuations are made. OTC
Bulletin Board securities are valued at the mean of the closing bid and asked prices. A security that is listed or traded on


 

T. ROWE PRICE INSTITUTIONAL INTERNATIONAL DISCIPLINED EQUITY FUND

more than one exchange is valued at the quotation on the exchange determined to be the primary market for such
security. Listed securities not traded on a particular day are valued at the mean of the closing bid and asked prices for
domestic securities and the last quoted sale or closing price for international securities.

For valuation purposes, the last quoted prices of non-U.S. equity securities may be adjusted to reflect the fair value of
such securities at the close of the NYSE. If the fund determines that developments between the close of a foreign market
and the close of the NYSE will affect the value of some or all of its portfolio securities, the fund will adjust the previous
quoted prices to reflect what it believes to be the fair value of the securities as of the close of the NYSE. In deciding
whether it is necessary to adjust quoted prices to reflect fair value, the fund reviews a variety of factors, including
developments in foreign markets, the performance of U.S. securities markets, and the performance of instruments
trading in U.S. markets that represent foreign securities and baskets of foreign securities. The fund may also fair value
securities in other situations, such as when a particular foreign market is closed but the fund is open. The fund uses
outside pricing services to provide it with quoted prices and information to evaluate or adjust those prices. The fund
cannot predict how often it will use quoted prices and how often it will determine it necessary to adjust those prices to
reflect fair value. As a means of evaluating its security valuation process, the fund routinely compares quoted prices, the
next day’s opening prices in the same markets, and adjusted prices.

Actively traded equity securities listed on a domestic exchange generally are categorized in Level 1 of the fair value
hierarchy. Non-U.S. equity securities generally are categorized in Level 2 of the fair value hierarchy despite the
availability of quoted prices because, as described above, the fund evaluates and determines whether those quoted prices
reflect fair value at the close of the NYSE or require adjustment. OTC Bulletin Board securities, certain preferred
securities, and equity securities traded in inactive markets generally are categorized in Level 2 of the fair value
hierarchy.

Investments denominated in foreign currencies are translated into U.S. dollar values each day at the prevailing exchange
rate, using the mean of the bid and asked prices of such currencies against U.S. dollars as quoted by a major bank.

Investments in mutual funds are valued at the mutual fund’s closing NAV per share on the day of valuation and are
categorized in Level 1 of the fair value hierarchy.

Thinly traded financial instruments and those for which the above valuation procedures are inappropriate or are
deemed not to reflect fair value are stated at fair value as determined in good faith by the Valuation Committee. The
objective of any fair value pricing determination is to arrive at a price that could reasonably be expected from a current
sale. Financial instruments fair valued by the Valuation Committee are primarily private placements, restricted
securities, warrants, rights, and other securities that are not publicly traded.

Subject to oversight by the Board, the Valuation Committee regularly makes good faith judgments to establish and
adjust the fair valuations of certain securities as events occur and circumstances warrant. For instance, in determining
the fair value of an equity investment with limited market activity, such as a private placement or a thinly traded public
company stock, the Valuation Committee considers a variety of factors, which may include, but are not limited to, the
issuer’s business prospects, its financial standing and performance, recent investment transactions in the issuer, new
rounds of financing, negotiated transactions of significant size between other investors in the company, relevant market
valuations of peer companies, strategic events affecting the company, market liquidity for the issuer, and general
economic conditions and events. In consultation with the investment and pricing teams, the Valuation Committee will
determine an appropriate valuation technique based on available information, which may include both observable and
unobservable inputs. The Valuation Committee typically will afford greatest weight to actual prices in arm’s length
transactions, to the extent they represent orderly transactions between market participants, transaction information can
be reliably obtained, and prices are deemed representative of fair value. However, the Valuation Committee may also
consider other valuation methods such as market-based valuation multiples; a discount or premium from market value
of a similar, freely traded security of the same issuer; or some combination. Fair value determinations are reviewed on a
regular basis and updated as information becomes available, including actual purchase and sale transactions of the
issue. Because any fair value determination involves a significant amount of judgment, there is a degree of subjectivity


 

T. ROWE PRICE INSTITUTIONAL INTERNATIONAL DISCIPLINED EQUITY FUND

inherent in such pricing decisions, and fair value prices determined by the Valuation Committee could differ from
those of other market participants. Depending on the relative significance of unobservable inputs, including the
valuation technique(s) used, fair valued securities may be categorized in Level 2 or 3 of the fair value hierarchy.

Valuation Inputs
The following table summarizes the fund’s financial instruments, based on the inputs used to determine their fair values
on July 31, 2020 (for further detail by category, please refer to the accompanying Portfolio of Investments):

($000s)    Level 1  Level 2  Level 3  Total Value  
Assets           
Common Stocks  $  3,270  $              252,157  $                $              255,427 
Preferred Stocks      4,401    4,401 
Short-Term Investments    23,533      23,533 
Total  $  26,803  $             256,558  $               $              283,361